In this study, we first found that HBV-infected HCC patients with high tumor NEDD4 expression experienced superior cumulative survival over those with low tumor NEDD4 expression and that high NEDD4 expression in HBV-positive cell lines inhibited proliferation, migration, and invasion. Here, NEDD4 is linked to neoplasm.